Skip to main content
. 2012 Oct 22;2:756. doi: 10.1038/srep00756

Figure 2. Inhibition of replication of virus A/Aichi/2/68 (H3N2).

Figure 2

Virus titer (log TCID50/ml) in the presence of nanocomposites and controls. Without sample (1), TiO2 nanoparticles (2), TiO2 ·PL nanocomposite (3); DNA1 and DNA2 fragments (4, 5), PL-DNA1 and PL-DNA2 conjugates (6, 7), DNA1and DNA2 fragments in the presence of LlipofectamineTM 2000 (lpf) (8, 9), and TiO2 ·PL- DNA1 and TiO2 ·PL-DNA2 nanocomposites (10, 11). Light-coloured columns correspond to samples with noncomplementary oligonucleotides. Concentrations of nanocomposites and controls in the medium were 5 μg/ml for TiO2 nanoparticles and 0.1 μM for DNA fragment. Experiments were performed in three independent series.